| Term 
 
        | Imitrex, Maxalt, Axert, Frova, Relpax, Amerge, Zomig |  | Definition 
 
        | Class: Triptan   MAE: agonize 5ht ab/ad agonists in vasculature in order to vasoconstric, inhibits pain signal, inhibit vasoactive peptides   Drug-drug: MAOIs, CYP3a4s, SSRIs   Fastest:Maxalt Slowest:Zomig Lowest reoccuring: Zomig   A/E: Maxalt interacts with propanolol   Metabolized:cyp3a4 Formulas: PO, subq (imitrex) nasal (imitrex zomig) Contraindication: heart disease, HTN, stroke, preg,   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   ergotamine/dihydroergotamine   Clinical use: prolonged duration migraines not 1st line of defense   MAE: 5ht 1b/1d agonists Pharmkinetics: poor bioavail 2-5%  A/E: N/V rebound headaches C/I: CAD,PVD, HTN,HepaticC/Renal disease   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | no dependence, no rebound HA   admin: sq IM IV with antiemetic C/I: elderly, elderly, HTN, heart disease, MAOIs |  | 
        |  | 
        
        | Term 
 
        | First-line agents for migraine |  | Definition 
 
        | NSAIDs :high dose ASPIRIN:high dose TYLENOL :high dose combo-products |  | 
        |  | 
        
        | Term 
 
        | mono- or adjunct therapy for migraines |  | Definition 
 
        | antiemetics- reglan, thorazine, prochlorperazine   benzos opiods barbs: not for chronic   Prevention: beta block, ca channels, TCAs, anticonvulsants, Ergot |  | 
        |  |